1996
Serial myocardial perfusion imaging with Tc-99m-labeled myocardial perfusion imaging agents in patients receiving thrombolytic therapy for acute myocardial infarction
Wackers F. Serial myocardial perfusion imaging with Tc-99m-labeled myocardial perfusion imaging agents in patients receiving thrombolytic therapy for acute myocardial infarction. Developments In Cardiovascular Medicine 1996, 173: 1-12. DOI: 10.1007/978-94-009-0115-5_1.Peer-Reviewed Original ResearchAcute myocardial infarctionThrombolytic therapyMyocardial infarctionInfarct arteryMyocardial perfusionRecurrent myocardial infarctionInfarct artery patencyLong-term mortalityAppropriate adjunctive therapyNovel treatment strategiesTerm mortalityAdjunctive therapyArtery patencyAcute infarctionHibernating myocardiumConventional therapyUnfavorable outcomeAntithrombotic agentsTreatment strategiesComparative efficacyReocclusionPatientsInfarctionTherapyBeneficial effects
1993
Assessing myocardial reperfusion with technetium-99m-labeled myocardial perfusion agents: basic concepts and clinical applications.
Sinusas AJ, Wackers FJ. Assessing myocardial reperfusion with technetium-99m-labeled myocardial perfusion agents: basic concepts and clinical applications. American Journal Of Cardiac Imaging 1993, 7: 24-38. PMID: 10148381.Peer-Reviewed Original ResearchConceptsVessel patencyPerfusion agentManagement of patientsAcute myocardial infarctionAssessment of reperfusionClinical applicationAcute coronary reperfusionMyocardial perfusion agentThrombolytic eraCoronary reperfusionMyocardial reperfusionPotential clinical applicationsMyocardial salvageMyocardial infarctionNoninvasive evaluationReperfusionPatencyResidual viabilityThrombolysisPatientsUnique biological propertiesBiological propertiesReocclusionInfarctionPerfusion